iBridge Capital

iBridge Capital is a healthcare-focused venture capital and private equity firm that specializes in cross-border investments between the United States and China. The firm focuses on identifying and incubating high-growth life science companies, particularly those developing innovative therapeutics, medical devices, and digital health solutions. iBridge Capital leverages its deep industry expertise and extensive network to facilitate the global commercialization of medical breakthroughs. By bridging the gap between Western innovation and the Asian market, the firm plays a critical role in the development of the international biotech ecosystem.